Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 301

 

Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Advertise Contacts Login 
     

    Article Cited by others

ORIGINAL ARTICLE

Postexposure prophylaxis for Lassa fever: Experience from a recent outbreak in Nigeria

Isa Samson E, Okwute Attah, Iraoyah Kelly O, Nathan Shehu Y, Simji Gomerep S, Okolo Mark O, Anejo-Okopi Joseph, Spicola Daria, Isa Daisy E

Year : 2016| Volume: 57| Issue : 4 | Page no: 246-250

   This article has been cited by
 
1 An insight into Ribavirin post-exposure prophylaxis for Lassa fever infection prevention amongst health-care workers in a specialist hospital in North-Central Nigeria
ChidiebereNwakamma Ononuju,LuckyLohnan Changkat,ChidozieValentine Adiukwu,OgediBlaise Okwaraoha,UzomaEmmanuel Chinaka,YakubuAhmed Ashuku,StellaUzoma Chinaka,ElizabethChioma Ezeaku,HassanI Ikrama
Journal of Medicine in the Tropics. 2020; 22(2): 122
[Pubmed]  [Google Scholar] [DOI]
2 A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks—results from the Lassa fever pilot
Louise Sigfrid,Catrin Moore,Alex P. Salam,Nicola Maayan,Candyce Hamel,Chantelle Garritty,Vittoria Lutje,Brian Buckley,Karla Soares-Weiser,Rachel Marshall,Mike Clarke,Peter Horby
BMC Medicine. 2019; 17(1)
[Pubmed]  [Google Scholar] [DOI]
3 Use of ribavirin in viruses other than hepatitis C. A review of the evidence
German Ramírez-Olivencia,Miriam Estébanez,Francisco Javier Membrillo,Maria del Carmen Ybarra
Enfermedades infecciosas y microbiologia clinica (English ed.). 2019;
[Pubmed]  [Google Scholar] [DOI]
4 Uso de ribavirina en virus distintos de la hepatitis C . Una revisión de la evidencia
German Ramírez-Olivencia,Miriam Estébanez,Francisco Javier Membrillo,Maria del Carmen Ybarra
Enfermedades Infecciosas y Microbiología Clínica. 2018;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article